CYT-108 is a revolutionary biologic therapy for treating osteoarthritis. When injected into the afflicted joint, CYT-108 binds to cartilage-destroying enzymes, rendering them inactive. This "cartilage-protecting" feature of CYT-108 slows down and eventually attenuates the progression of osteoarthritis, providing relief to the patient and enhancing their quality of life.
